z-logo
Premium
Protective effect of diphenylmethyl selenocyanate against CCl 4 ‐induced hepatic injury
Author(s) -
Das Rajat Kumar,
Hossain Sk. Ugir,
Bhattacharya Sudin
Publication year - 2007
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.1230
Subject(s) - carbon tetrachloride , chemistry , pharmacology , dna damage , necrosis , in vivo , apoptosis , comet assay , medicine , biochemistry , dna , biology , microbiology and biotechnology , organic chemistry
Organoselenocyanates represent an important class of chemopreventive agent, which possess antioxidative, antimutagenic as well as cancer chemopreventive properties. The present study is an attempt to evaluate the protective effect of diphenylmethyl selenocyanate — a synthetic organoselenocyanate against carbon tetrachloride (CCl 4 )‐induced hepatic damage in Swiss albino mice in vivo . Mice were pretreated with the Se‐compound orally in a duration dependent manner (7 and 15 days) to observe its protective action against an acute toxic dose (24 h) of CCl 4 (single injection at a dose of 20 µl and 50 µl kg −1 b.w.) that induced hepatic necrosis and caused DNA damage (strand breaks) in the hepatocytes. This study revealed that pretreatment with the Se‐compound reduced the extent of massive hepatic necrosis in a duration dependent manner, but it had no modulatory effect on hepatocellular apoptosis caused by acute toxic doses of CCl 4 . It was also found that the Se‐compound could significantly ( P < 0.01) prevent the CCl 4 ‐induced elevation of DNA damage in hepatocytes measured by comet assay in a duration dependent manner. So these findings will further strengthen the view that organoselenocyanate is an effective chemopreventive agent against acute hepatic damage, caused by halogenated alkanes such as CCl 4 . Copyright © 2007 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here